MELPIDA is proposed for the treatment of subjects with SPG50 and targets neuronal cells to deliver a fully functional human AP4M1 cDNA copy via intrathecal inj…

Spasticity, MuscleMicrocephalyIntellectual Deficiency+3 more

~Estimated

~$10 – $8,750

Elpida Therapeutics SPCNCT05518188

Observational

Targeted Fortification of Donor Breast Milk in Preterm Infants

This study is a randomized controlled trial comparing standard fortification of donor breast milk to targeted fortification of donor breast milk in preterm inf…

Prematurity; ExtremeFailure to Thrive in NewbornGrowth Retardation+2 more

~Estimated

~$10 – $6,250

Columbia UniversityNCT04294368

Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation

Optimal diagnostic management and underlying pathophysiological mechanisms of selective fetal growth restriction (sFGR) in monochorionic diamniotic (MCDA) twin…

Twin; Pregnancy, Affecting Fetus or NewbornFetal Growth RetardationTwin Monochorionic Diamniotic Placenta+1 more

~Estimated

~$10 – $750

Leiden University Medical CenterNCT05952583